Immunization against neonatal tetanus in New Guinea
- PMID: 5312998
- PMCID: PMC2427681
Immunization against neonatal tetanus in New Guinea
Abstract
THIS PAPER DESCRIBES: (1) a continuation of the study reported in 1965 of tetanus antitoxin titres among women after primary immunization with plain, AlPO(4)-adsorbed or oil adjuvant toxoids; (2) the effect of age and of abscess formation due to oil adjuvants on antitoxin response; and (3) a comparative study of titres in some women of the study groups who received either a plain or an AlPO(4) toxoid booster injection in pregnancy.The results support our previous recommendation to use aluminium adjuvant toxoid in the prevention of neonatal tetanus. Mean maternal protective antitoxin levels were maintained for 40 months but not for 54 months after 2 primary injections and booster response was higher in those immunized with this toxoid than in those immunized with plain toxoid. Also, the use of AlPO(4) toxoid as booster stimulated a higher antitoxin response than did the use of plain toxoid. Mean protective levels induced by oil adjuvant toxoids (1 injection) persisted for the same time as for the adsorbed toxoid (2 injections). Age did not significantly affect the level of antitoxin response, whereas abscess formation was associated with a higher level.Pregnancy appeared to favour the incidence of antitoxin responders to adsorbed toxoids. Failure to respond to primary immunization with 2 injections of adsorbed toxoid occurred in 7% of women while 100% responded to the oil adjuvant toxoids. Induction of abscess formation precludes use of the latter toxoids, however. Additional studies are needed on the influence of larger antigen doses on the primary response in different ethnic and ecological situations and on the influence of smaller antigen doses on the booster response where repeated booster injections are indicated.
Similar articles
-
Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.Bull World Health Organ. 1970;43(3):453-9. Bull World Health Organ. 1970. PMID: 5312999 Free PMC article.
-
Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.Bull World Health Organ. 1970;43(3):469-78. Bull World Health Organ. 1970. PMID: 5313001 Free PMC article.
-
Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids.Bull World Health Organ. 1965;32(5):683-97. Bull World Health Organ. 1965. PMID: 5294183 Free PMC article.
-
Assessments of vaccines for prenatal immunization.Vaccine. 2013 Aug 28;31 Suppl 4:D27-30. doi: 10.1016/j.vaccine.2013.02.031. Vaccine. 2013. PMID: 23973343 Review.
-
[Current problems related to the further reduction and elimination of tetanus (literature review)].Zh Mikrobiol Epidemiol Immunobiol. 1972 Dec;49(12):36-43. Zh Mikrobiol Epidemiol Immunobiol. 1972. PMID: 4118731 Review. Russian. No abstract available.
Cited by
-
Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.Bull World Health Organ. 1970;43(3):453-9. Bull World Health Organ. 1970. PMID: 5312999 Free PMC article.
-
Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.Bull World Health Organ. 1970;43(3):469-78. Bull World Health Organ. 1970. PMID: 5313001 Free PMC article.
-
Vaccines for women for preventing neonatal tetanus.Cochrane Database Syst Rev. 2015 Jul 6;2015(7):CD002959. doi: 10.1002/14651858.CD002959.pub4. Cochrane Database Syst Rev. 2015. PMID: 26144877 Free PMC article.
-
Control of neonatal tetanus.Indian J Pediatr. 1985 Jul-Aug;52(417):329-41. doi: 10.1007/BF02806614. Indian J Pediatr. 1985. PMID: 4093168 No abstract available.
-
The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid.Bull World Health Organ. 1973;49(6):615-26. Bull World Health Organ. 1973. PMID: 4548388 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources